Cargando…

Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death

Direct local delivery of immunogenic cell death (ICD) inducers to a tumor site is an attractive approach for leading ICD effectively, due to enabling the concentrated delivery of ICD inducers to the tumor site. Herein, we prepared doxorubicin (DOX)-loaded poly(lactic-co-glycolic acid) (PLGA) nanopar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Yongwhan, Yoon, Hong Yeol, Kim, Jeongrae, Yang, Suah, Lee, Jaewan, Choi, Ji Woong, Moon, Yujeong, Kim, Jinseong, Lim, Seungho, Shim, Man Kyu, Jeon, Sangmin, Kwon, Ick Chan, Kim, Kwangmeyung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759870/ https://www.ncbi.nlm.nih.gov/pubmed/33260446 http://dx.doi.org/10.3390/pharmaceutics12121165

Ejemplares similares

Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses
por: Kim, Jeongrae, et al.
Publicado: (2022)

Deep Tumor Penetration of Doxorubicin-Loaded Glycol Chitosan Nanoparticles Using High-Intensity Focused Ultrasound
por: Choi, Yongwhan, et al.
Publicado: (2020)

Cathepsin B-Overexpressed Tumor Cell Activatable Albumin-Binding Doxorubicin Prodrug for Cancer-Targeted Therapy
por: Cho, Hanhee, et al.
Publicado: (2021)

Preclinical development of carrier-free prodrug nanoparticles for enhanced antitumor therapeutic potential with less toxicity
por: Shim, Man Kyu, et al.
Publicado: (2022)

All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy
por: Song, Sukyung, et al.
Publicado: (2023)

Implantable micro-scale LED device guided photodynamic therapy to potentiate antitumor immunity with mild visible light
por: Choi, Jiwoong, et al.
Publicado: (2022)

Dual Drug Delivery of Sorafenib and Doxorubicin from PLGA and PEG-PLGA Polymeric Nanoparticles
por: Babos, György, et al.
Publicado: (2018)

Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death
por: Moon, Yujeong, et al.
Publicado: (2022)

Injectable Hydrogel-Based Combination Cancer Immunotherapy for Overcoming Localized Therapeutic Efficacy
por: Kim, Jeongrae, et al.
Publicado: (2022)

Local penetration of doxorubicin via intrahepatic implantation of PLGA based doxorubicin-loaded implants
por: Gao, Li, et al.
Publicado: (2019)

Doxorubicin and CD-CUR inclusion complex co-loaded in thermosensitive hydrogel PLGA-PEG-PLGA localized administration for osteosarcoma
por: Yang, Zhiming, et al.
Publicado: (2020)

Pharmacodynamics and pharmacokinetics of PLGA-based doxorubicin-loaded implants for tumor therapy
por: He, Peng, et al.
Publicado: (2022)

Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy
por: Cho, Hanhee, et al.
Publicado: (2022)

Efficient Chemotherapy of Rat Glioblastoma Using Doxorubicin-Loaded PLGA Nanoparticles with Different Stabilizers
por: Wohlfart, Stefanie, et al.
Publicado: (2011)

Doxorubicin Loaded PLGA Nanoparticle with Cationic/Anionic Polyelectrolyte Decoration: Characterization, and Its Therapeutic Potency
por: Tsai, Li-Hui, et al.
Publicado: (2021)

Mesenchymal Stem Cell-Mediated Deep Tumor Delivery of Gold Nanorod for Photothermal Therapy
por: Yun, Wan Su, et al.
Publicado: (2022)

Immunogenicity of pulsatile-release PLGA microspheres for single-injection vaccination
por: Guarecuco, Rohiverth, et al.
Publicado: (2018)

Chitosan-Dextran sulfate coated doxorubicin loaded PLGA-PVA-nanoparticles caused apoptosis in doxorubicin resistance breast cancer cells through induction of DNA damage
por: Siddharth, Sumit, et al.
Publicado: (2017)

Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy
por: Moon, Yujeong, et al.
Publicado: (2023)

Supermagnetic Human Serum Albumin (HSA) Nanoparticles and PLGA-Based Doxorubicin Nanoformulation: A Duet for Selective Nanotherapy
por: Malinovskaya, Julia, et al.
Publicado: (2022)

Double-Walled Poly-(D,L-lactide-co-glycolide) (PLGA) and Poly(L-lactide) (PLLA) Nanoparticles for the Sustained Release of Doxorubicin
por: Cardoso, M. Margarida, et al.
Publicado: (2021)

Injectable In-Situ Forming Depot Based on PLGA and PLGA-PEG-PLGA for Sustained-Release of Risperidone: In Vitro Evaluation and Pharmacokinetics in Rabbits
por: Rezaeian Shiadeh, Seyedeh Nesa, et al.
Publicado: (2023)

Co-encapsulation of magnetic Fe(3)O(4) nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery
por: Jia, Yanhui, et al.
Publicado: (2012)

PLGA Nanoparticles Containing VCAM-1 Inhibitor Succinobucol and Chemotherapeutic Doxorubicin as Therapy against Primary Tumors and Their Lung Metastases
por: Wang, Jie, et al.
Publicado: (2023)

In vivo toxicity evaluation of tumor targeted glycol chitosan nanoparticles in healthy mice: repeated high-dose of glycol chitosan nanoparticles potentially induce cardiotoxicity
por: Chang, Hyeyoun, et al.
Publicado: (2023)

Preparation of PLGA Nanoparticles by Milling Spongelike PLGA Microspheres
por: Lee, Jimin, et al.
Publicado: (2022)

Sustained in vitro interferon-beta release and in vivo toxicity of PLGA and PEG-PLGA nanoparticles
por: Fodor-Kardos, Andrea, et al.
Publicado: (2020)

Enhanced activity of doxorubicin in drug resistant A549 tumor cells by encapsulation of P-glycoprotein inhibitor in PLGA-based nanovectors
por: XU, LIANG, et al.
Publicado: (2014)

Overcoming MDR by Associating Doxorubicin and pH-Sensitive PLGA Nanoparticles Containing a Novel Organoselenium Compound—An In Vitro Study
por: Macedo, Letícia Bueno, et al.
Publicado: (2021)

In Vitro and In Vivo Effect of pH-Sensitive PLGA-TPGS-Based Hybrid Nanoparticles Loaded with Doxorubicin for Breast Cancer Therapy
por: Fernandes, Renata S., et al.
Publicado: (2022)

Protein Loading into Spongelike PLGA Microspheres
por: Kim, Yuyoung, et al.
Publicado: (2021)

DPD simulations on morphologies and structures of blank PLGA-b-PEG-b-PLGA polymeric micelles and docetaxel-loaded PLGA-b-PEG-b-PLGA polymeric micelles
por: Wang, Mengyao, et al.
Publicado: (2022)

PLGA Particles in Immunotherapy
por: Horvath, Dennis, et al.
Publicado: (2023)

Thermosensitive PLGA–PEG–PLGA Hydrogel as Depot Matrix for Allergen-Specific Immunotherapy
por: Heine, Sonja, et al.
Publicado: (2022)

Assessment of the Effect of PLGA Co-polymers and PEG on the Formation and Characteristics of PLGA-PEG-PLGA Co-block Polymer Using Statistical Approach
por: Sulaiman, Teuku Nanda Saifullah, et al.
Publicado: (2019)

Glycol chitosan nanoparticles as specialized cancer therapeutic vehicles: Sequential delivery of doxorubicin and Bcl-2 siRNA
por: Yoon, Hong Yeol, et al.
Publicado: (2014)

PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity
por: Silva, A. L., et al.
Publicado: (2016)

Multifunctional Polyethylene Glycol (PEG)-Poly (Lactic-Co-Glycolic Acid) (PLGA)-Based Nanoparticles Loading Doxorubicin and Tetrahydrocurcumin for Combined Chemoradiotherapy of Glioma
por: Zhang, Xingzhen, et al.
Publicado: (2019)

PEGylated apoptotic protein-loaded PLGA microspheres for cancer therapy
por: Byeon, Hyeong Jun, et al.
Publicado: (2015)

Caspase-3/-7-Specific Metabolic Precursor for Bioorthogonal Tracking of Tumor Apoptosis
por: Shim, Man Kyu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vhfmgk327ke0lcidsv32pn0v7t